Clinical Trial Update: STILDEP: Zolpidem in Depressive and Dysthimic Patients [Phase 4]

View source ↗

Summary

Sanofi-sponsored Phase 4 trial evaluating zolpidem in patients with insomnia and depressive disorders (including dysthymia) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Major Depressive Disorder
• Persistent Depressive Disorder

Drugs mentioned

• Zolpidem (zolpidem)

Snippet

Sponsor: Sanofi | Conditions: Sleep Initiation and Maintenance Disorders, Depression | Phase 4 | Status: COMPLETED